GSOL [GLOBAL SOURCES] 6-K: st YEAR 2015 / 1 RESULTS OF OPERATIONS

[st YEAR 2015 / 1 RESULTS OF OPERATIONS OF GLOBAL SOURCES LTD. The following discussion of our financial condition and results of operations should Overview We are a leading business-to-business (B2B) media company and a primary facilitator of two-way trade with Greater China. The core business is facilitating trade from Greater China to the world, using a wide range of] [GLOBAL SOURCES LTD. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (In U.S. Dollars Thousands, Except Number of Shares and Per Share Data) As at March 31, As at December 31, 2015 2014 (Unaudited) ASSETS Current assets Cash and cash equivalents $ 92,802 $ 90,223 Term deposits with banks 6,676 4,285 Financial assets, available-for-sale 4,155 3,952 Accounts receivables, net 1,868 2,269 Receivables from] []

By | 2016-03-30T12:32:48+00:00 May 22nd, 2015|Categories: Chinese Stocks, GSOL, Webplus ver|Tags: , , , , , |0 Comments

CAAS [CHINA AUTOMOTIVE SYSTEMS] S-3/A: (Original Filing)

[] [CHINA AUTOMOTIVE SYSTEMS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [ — ], 20[ — ] Senior Debt Securities Table of Contents (1) Page ARTICLE 1 DEFINITIONS 5 Section 1.01 Definitions of Terms 5 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 8 Section 2.01 Designation and Terms of Securities 8 Section 2.02 Form of] [CHINA AUTOMOTIVE SYSTEMS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [ — ], 20[ — ] Subordinated Debt Securities Table of Contents (1) Page ARTICLE 1 DEFINITIONS 5 Section 1.01 Definitions of Terms 5 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 5 Section 2.01 Designation and Terms of Securities 8 Section 2.02 Form of] [May 22, 2015 China Automotive Systems, Inc. Re: China Automotive Systems, Inc. Registration Statement on Form S-3 for Primary Sale of Shares of Common Stock by the Company and Resale of Shares of Common Stock by the Selling Shareholders with an aggregate public offering price of up to US$200,000,000 Ladies and Gentlemen: Company Registration Statement Act Commission We have acted] [China Automotive Systems, Inc. Computation of Ratio of Earnings to Fixed Charges (Dollars in thousands) Three Fiscal Year Ended December 31, 2015 2014 2013 2012 2011 2010 Earnings: Income before income taxes and equity in earnings of affiliated companies $ 9,736 $ 46,081 $ 38,241 $ 30,069 $ 52,099 $ 71,416 Add (deduct): Fixed charges 637 2,549 2,298 3,464 5,393] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in this Amendment No. 1 to the Registration Statement on Form S-3 of our report dated March 26, 2015, relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in China Automotive Systems, Inc.’s Annual Report on Form]

BORN [CHINA NEW BORUN] 6-K: Confidential May 21, 2015 China New Borun Announces

[Confidential May 21, 2015 China New Borun Announces First Quarter 2015 Unaudited Financial Results Beijing, China, May 21, 2015 – China New Borun Corporation (NYSE: BORN; “Borun” or the “Company”), a leading producer and distributor of corn-based edible alcohol in China, today announced its unaudited financial results for the first quarter ended March 31, 2015. baijiu Mr. Jinmiao Wang, Chairman] [FORM 6-K China New Borun Corporation Bohai Industrial Park Yangkou Town Shouguang, Shandong 262715 People’s Republic of China x Form 20-F ¨ Form 40-F ¨ ¨ China New Borun Corporation Terence Chen Chief Financial Officer Press release dated May 21, 2015 6-K 1 v411514_6k.htm FORM 6-K]

By | 2016-03-24T00:36:48+00:00 May 22nd, 2015|Categories: BORN, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)

[SKYSTAR BIO-PHARMACEUTICAL COMPANY ANNOUNCES RECEIPT OF Xi’an, China, May 22, 2015 – Skystar Bio-Pharmaceutical Company (Nasdaq: SKBI), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, announced today that the Company received a notification from the Nasdaq Stock Market (“Nasdaq”) informing the Company that since it had not filed its Quarterly Report on Form 10-Q for] [By Electronic Delivery to: bing@skystarbio-pharmaceutical.com; aorudjev@schiffhardin.com; scramer@skystarbio-pharmaceutical.com May 21, 2015 Mr. Bing Mei Chief Financial Officer Skystar Bio-Pharmaceutical Company 4/F Building B, Chuangye Square, No. 48 Keji Road Gaoxin District, Xi’an Shaanxi Province, P.R. China Re: Skystar Bio-Pharmaceutical Company (the “Company”) Nasdaq Symbol: SKBI Dear Mr. Mei: As you know, since we have not received the Company’s Form 10-Q for] []

By | 2016-03-27T15:16:26+00:00 May 22nd, 2015|Categories: Chinese Stocks, SEC Original, SKBI|Tags: , , , , , |0 Comments

CAAS [CHINA AUTOMOTIVE SYSTEMS] S-3/A:

[] [CHINA AUTOMOTIVE SYSTEMS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [ — ], 20[ — ] Senior Debt Securities Table of Contents (1) Page ARTICLE 1 DEFINITIONS 5 Section 1.01 Definitions of Terms 5 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 8 Section 2.01 Designation and Terms of Securities 8 Section 2.02 Form of] [CHINA AUTOMOTIVE SYSTEMS, INC., Issuer AND [TRUSTEE], Trustee INDENTURE Dated as of [ — ], 20[ — ] Subordinated Debt Securities Table of Contents (1) Page ARTICLE 1 DEFINITIONS 5 Section 1.01 Definitions of Terms 5 ARTICLE 2 ISSUE, DESCRIPTION, TERMS, EXECUTION, REGISTRATION AND EXCHANGE OF SECURITIES 5 Section 2.01 Designation and Terms of Securities 8 Section 2.02 Form of] [May 22, 2015 China Automotive Systems, Inc. Re: China Automotive Systems, Inc. Registration Statement on Form S-3 for Primary Sale of Shares of Common Stock by the Company and Resale of Shares of Common Stock by the Selling Shareholders with an aggregate public offering price of up to US$200,000,000 Ladies and Gentlemen: Company Registration Statement Act Commission We have acted] [China Automotive Systems, Inc. Computation of Ratio of Earnings to Fixed Charges (Dollars in thousands) Three Fiscal Year Ended December 31, 2015 2014 2013 2012 2011 2010 Earnings: Income before income taxes and equity in earnings of affiliated companies $ 9,736 $ 46,081 $ 38,241 $ 30,069 $ 52,099 $ 71,416 Add (deduct): Fixed charges 637 2,549 2,298 3,464 5,393] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in this Amendment No. 1 to the Registration Statement on Form S-3 of our report dated March 26, 2015, relating to the consolidated financial statements and the effectiveness of internal control over financial reporting, which appears in China Automotive Systems, Inc.’s Annual Report on Form]

SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: SKYSTAR BIO-PHARMACEUTICAL COMPANY ANNOUNCES RECEIPT OF Xi’an, China,

[SKYSTAR BIO-PHARMACEUTICAL COMPANY ANNOUNCES RECEIPT OF Xi’an, China, May 22, 2015 – Skystar Bio-Pharmaceutical Company (Nasdaq: SKBI), a China-based manufacturer and distributor of veterinary medicine, vaccines, micro-organisms and feed additives, announced today that the Company received a notification from the Nasdaq Stock Market (“Nasdaq”) informing the Company that since it had not filed its Quarterly Report on Form 10-Q for] [By Electronic Delivery to: bing@skystarbio-pharmaceutical.com; aorudjev@schiffhardin.com; scramer@skystarbio-pharmaceutical.com May 21, 2015 Mr. Bing Mei Chief Financial Officer Skystar Bio-Pharmaceutical Company 4/F Building B, Chuangye Square, No. 48 Keji Road Gaoxin District, Xi’an Shaanxi Province, P.R. China Re: Skystar Bio-Pharmaceutical Company (the “Company”) Nasdaq Symbol: SKBI Dear Mr. Mei: As you know, since we have not received the Company’s Form 10-Q for] []

By | 2016-03-27T15:19:05+00:00 May 22nd, 2015|Categories: Chinese Stocks, SKBI, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar